Advertising

Takeda admits running bad ads

The company said it used "inappropriate expressions" in promotions of a blood pressure medication.

Raid at Novartis Tokyo

The reason: Diovan.

FDA may ditch some TV ad requirements

A consumer survey will shape the regulator's position.

Google ads target off-limits Canadians

Canada's Office of the Privacy Commissioner says the search giant failed to protect what qualifies as sensitive user information.

New owner to publish MedAdNews biannually

New owner to publish MedAdNews biannually

By

A month after UBM Canon closed the B2B magazine, marketing firm Outcomes LLC announced its return to twice-a-year publication.

FTC wants media to be wary of ads

The agency says outlets need to rethink running ads that make false claims.

Japan lodges complaint against Novartis

The Health Ministry alleges Novartis exaggerated advertising for its blood pressure drug Diovan.

The year's most popular stories

The year's most popular stories

Our year-end list captures the 10 that sparked heaviest interest.

Draft legislation has advertisers on edge

Draft legislation has advertisers on edge

By

Lobbying groups say the ad tax draft proposal could wreak havoc throughout the ad industry and its partners, such as publishers and broadcasters, if it were to go through.

UK, Brazilian ads take top honors at Globals

UK, Brazilian ads take top honors at Globals

An organ-donation campaign with a Brazilian football tie-in, and a UK managed-access company's series of documentary films, took top honors.

Ariad hunkers down

Ariad hunkers down

By

The drugmaker's latest financial plans could power it through mid-2015.

TV interviews trigger Aegerion warning letter

TV interviews trigger Aegerion warning letter

By

The FDA's Bad Ad group says the drugmaker misbranded its cholesterol drug during interviews on CNBC.

WebMD is bringing former advertisers back on board

WebMD is bringing former advertisers back on board

By

The company says it recaptured some former advertisers and that third-quarter traffic is up compared with last year.

FDA peers into teenage brain

The regulator will study how teens perceive ads and if targeted media needs unique standards.

Intouch creates HCP content division

Intouch creates HCP content division

By

Growing client demand encouraged the agency to make its HCP content capabilities official.

Valeant leverages Rx sales force, YouTube for OTC brand

Valeant leverages Rx sales force, YouTube for OTC brand

By

The company is supporting its professional pitch for the acne drug with a micro-targeted marketing strategy.

Business briefs: Eisai, AHRQ, mWellnesss

Eisai uses a lawsuit to prompt the DEA, AHRQ gets a new director, mWellness runs into adherence issues.

AMA to shutter newspaper amid ad turmoil

AMA to shutter newspaper amid ad turmoil

By

American Medical News' 55-year publishing run will come to a close this year, the AMA, its publisher, said today.

Dendreon lowers expectations, touts DTC effort

By

The company narrowed its second quarter loss, but said its national TV campaign is driving an uptick in consumer interest.

WebMD caps search, chooses in-house CEO Schlanger

WebMD caps search, chooses in-house CEO Schlanger

By

David Schlanger is the company's new chief executive, a role he's filled on an interim basis since May.

Merz web-copy shortcuts don't sit well with OPDP

By

FDA's Office of Prescription Drug Promotion issued an Untitled Letter over what it says are misleading copy and overstated efficacy claims online.

Astellas serves up dose of "reality" in DTC effort

Astellas serves up dose of "reality" in DTC effort

By

The drug maker's broadcast-heavy "OAB reality" campaign stresses the emotional toll on women.

J&J painkiller probe expands scrutiny of industry marketing

By

HHS is looking into how J&J marketed opioid painkiller Nucynta, adding to the firm's list of investigations and those of the industry as a whole.

Genetic testing firm airs TV spot as part of $5M ad buy

Genetic testing firm airs TV spot as part of $5M ad buy

By

23andMe aired its first TV ad Monday, in a bid to build the audience for DNA sequencing.

OPDP sends Warning Letter to Acorda

By

The ad watchdog flagged the drug maker for what it said was yet another misleading Ampyra promotional piece.

Publicis Omnicom merger puts healthcare clients under one roof

Publicis Omnicom merger puts healthcare clients under one roof

By

Over the weekend, Publicis Omnicom vaulted past WPP to become the world's biggest ad holding company. The task now falls on its co-CEOs to sort out any conflicts and prevent defections.

I'll take DTC for $10 million, Alex

I'll take DTC for $10 million, Alex

The Wizards of White Oak are spending $10 million on DTC ad research. Is this a wise use of sparse agency resources?

Twitter-Everyday Health deal means targeted Tweets

Twitter-Everyday Health deal means targeted Tweets

By

An Everyday Health-Twitter collaboration will deliver targeted promoted Tweets with health news, seasonal and lifestyle info

Business Briefs: Kantar Media, Janssen, Eli Lilly, Boehringer Ingelheim, Sanofi, Aveo

Healthcare critics continue to spend on anti-ACA ads; Janssen plunges into the microbiome; Lilly gets adult ADHD indication in UK; Sanofi pulls two drugs; and Aveo lays off 140.

Purdue puts Intermezzo DTC to bed

Purdue puts Intermezzo DTC to bed

By

Marketing partner Transcept pulled 90 sales reps and Purdue closed out the majority of its DTC outreach in March.

Email Newsletters